🚀
Enjoy a 7-Day Free Trial Thru Dec 06, 2024!
✨
Sign Up
Login
Free Sign-up
Login
7-Day Free Trial
Home
Homepage
Membership Levels
About Us
General Discussion
Complete Stock List
The book
Membership Data Coverage
Founder's Message
Free Trial
Referral Program
Partner Program
GuruFocus Podcast
Screeners
GuruFocus Screeners
All-In-One Screener
Ben Graham Lost Formula
Canadian Faster Growers
CEO Buys
CEO Buys after Price Drop > 20%
Dividend Kings 2023
Dividend Aristocrats 2023
Dividend Growth Portfolio
Dividend Income Portfolio
Fast Growers
Good Companies
Hedge Fund Guru Top 10 Aggregated
High Quality
High Quality Low Capex w ROE ROC min
High Quality & Low Capex
High Yield Insider Buys
Historical High Dividend Yields
International Gurus' Top Holdings
James Montier Short Screen
Margin Decliners
Mega Caps
Peter Lynch & Warren Buffett
Peter Lynch Growth w Lower Valuation
Peter Lynch S&L Traded Below Book
PFCF Screener
Piotroski Score Screener
Predictable Growth Companies
Profitable predictable margin expanders
Stocks Sold w less Cash
The Stalwarts
My Screeners
Create My Screener
Value Screens
Stock Ideas
All-In-One Screener
S&P 500 Map
S&P 500 Bubble
S&P 500 Aggregate
Buffett-Munger Screener
Industry Overview
Undervalued Predictable
Benjamin Graham Net-Net
52-week/3Y/5Y Lows
52-week/3Y/5Y Highs
Magic Formula(Greenblatt)
Dividend Stocks
Peter Lynch Screen
S&P500 Grid
Predictable Companies
Spin Off List
Merger and Acquisition List
Historical Low P/B List
Historical Low P/S List
High Short Interest
Upcoming Special Dividends
Delisted Stocks
Model Portfolios
Performances Overview
Most Broadly Held Portfolio
Most Weighted Portfolio
Buffett-Munger Top 25
GF Score <= 100 Top 25
Top 25 Undervalued Predictable
Top 25 52-week Low Predictable
Top 25 Historical Low P/S
Stock Comparison
Airline Stocks
Artificial Intelligence Stocks
Bank Stocks
Biotech Stocks
Blockchain Stocks
Chinese Stocks
Dividend Stocks
EV Stocks
Growth Stocks
Oil Stocks
Value Stocks
Virtual Reality Stocks
Compare More Stocks…
Gurus
Guru Trades
Latest Guru Picks
Real Time Picks
Guru Portfolio
Score Board
Mutual Funds
Top 10 Holdings
Sector Picks
International Picks
Aggregated Portfolio
Consensus Picks
Guru Bargains
Hot Picks
Download Guru Portfolios
Industry Trends
Geographic Trend
ETFs
Options Holdings
European Shorting
Guru Lists
Complete Guru List
Warren Buffett
Bill Gates
Mohnish Pabrai
Carl Icahn
George Soros
David Tepper
Seth Klarman
Bill Ackman
Joel Greenblatt
Charlie Munger
Michael Price
Julian Robertson
Chuck Akre
David Einhorn
Tom Gayner
My Guru Lists
Insiders
Insider Trading Tracker
Real-Time Insider Picks
CEO Buys/Sells
CFO Buys/Sells
Insider Trends
Insider Cluster
Guru + Insider Double Buys
Triple Buys/Sells
Canadian Insider
Chinese Insider
German Insider
Complete Insider List
Politician Trading Tracker
Real-Time Politician Picks
Complete Politician List
Nancy Pelosi
Mitch Mcconnell
Tommy Tuberville
Josh Gottheimer
Kevin Hern
Thomas R. Carper
Susie Lee
Lois Frankel
Market
US Market Valuation
Buffett Indicator
U.S. Treasury Yield Curve
U.S. Inflation Rate
Presidential Cycle and Stock Market
Shiller P/E
Shiller P/E by Sectors
GF Value for S&P 500 Index
Fed Net Liquidity
Buffett Assets Allocation
Latest IPOs
Global Market Valuation
Global Market Overview
USA
China
Japan
India
Canada
UK
France
Germany
Brazil
Australia
More...
Economic Indicators
Economic Indicators Overview
The Dow Jones Industrial Average (DJIA)
SP 500 Index
Nasdaq Composite Index
Gross Domestic Product (GDP)
Shiller PE
Ratio of Wilshire 5000 over GNP
Civilian Unemployment Rate
Russell 2000 Index
CBOE Volatility Index (VIX)
Total Nonfarm Payrolls: All Employees
More...
Sector & Industry Performance
Global Industry Overview
USA
Asia
Europe
Canada
UK/Ireland
Oceania
Latin America
Africa
India/Pakistan
Articles
Articles
Editors' Picks
Stock Market News
Q&A with Gurus
Guru Stock Picks
Insider Transaction
Earning Reports
Podcast
Earnings Call Transcripts
Software Stock News
Biotechnology Stock News
Hardware Stock News
Banks Stock News
Metals & Mining Stock News
Drug Manufacturers Stock News
All Articles
Submit Articles
Submit Article Online
Contributor Guidelines
Tools
Model Portfolios
All-In-One Screener
Data Batch Download
Guru Portfolio Download
Insider Data Download
Excel Add-In
Google Sheets Add-On
API
Manual of Stocks
DCF Calculator
WACC Calculator
Interactive Chart
Maps
Fund Letters Archive
Stock Comparison Table
Mobile App
Discussion Board
GuruGPT
Financial Calendar
Embed Widgets
Stock Market Holidays
Discussion
Discussion Board
Data
Pricing
Tutorials
Tutorials
Financial Glossary
FAQ
Change Log
Contact Us
Support
Chat Support
Create a ticket
Book Demo
User Engagement Meeting
469-248-6885
Status
Take Survey
Subscribe
Free Trial
Group Subscription
Refer a Friend and Earn One Month of Free Membership
GURUFOCUS.COM
STOCK LIST
Healthcare
Drug Manufacturers
Viatris Inc (MIL:1VTRS)
News
Viatris Inc
MIL
:1VTRS (USA) Â
€ 12.41
(0%)
Nov 28
On watch
P/E:
At Loss
P/B:
0.80
Market Cap:
€ 14.94B
($ 15.78B)
Enterprise V:
€ 28.17B
($ 29.75B)
Volume:
8.00
Avg Vol (2M):
213.00
Warning! GuruFocus detected 2 Severe warning signs with 1VTRS.
Try a 7-Day Free Trial
to check it out.
Trade In:
Volume:
8.00
Market Cap €:
14.94B
Market Cap $:
15.78B
PE Ratio:
At Loss
Avg Vol (2M):
213.00
Enterprise Value €:
28.17B
Enterprise Value $:
29.75B
PB Ratio:
0.80
Alerts
Website
Sources
Stock PDF
Dataset
Financial Download
Manual of Stocksâ„¢
Compare
0
Summary
30-Y Financials
Estimates
DCF
Dividend
Guru Trades
Insider
Interactive Chart
Transcripts
News
Compare
Stock PDF
Ownership
Operating
Checklist
Vote
Definitions
Viatris Inc (MIL:1VTRS) Stock News, Headlines & Updates
Viatris Inc Stock News from GuruFocus
Total 37
1
Nov 22, 2024
Viatris Inc (VTRS)'s Uncertain Future: Understanding the Barriers to Outperformance
GuruFocus News
•
9:01am
Nov 13, 2024
Chris Davis's Strategic Acquisition of Viatris Inc Shares
GuruFocus News
•
8:09am
Nov 11, 2024
Is Viatris Inc (VTRS) Set to Underperform? Analyzing the Factors Limiting Growth
GuruFocus News
•
9:03am
Nov 08, 2024
Is Viatris Inc (VTRS) Set to Underperform? Analyzing the Factors Limiting Growth
GuruFocus News
•
9:02am
Viatris Inc (VTRS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Debt Reduction
GuruFocus News
•
1:14am
Q3 2024 Viatris Inc Earnings Call Transcript
GuruFocus News
•
11:20pm
Nov 07, 2024
Viatris Inc (VTRS) Trading 9.17% Higher on Nov 7
GuruFocus News
•
10:10am
Viatris Inc (VTRS) Q3 2024 Earnings: Revenue Hits $3.8 Billion, EPS Falls Short at $0.08
GuruFocus News
•
7:11am
Viatris Reports Third Quarter Financial Results for 2024
PRNewswire
•
7:00am
Nov 05, 2024
Viatris Announces Third Quarter 2024 Dividend
PRNewswire
•
6:00am
Oct 29, 2024
Viatris Named to Forbes' World's Top Companies for Women 2024 List
PRNewswire
•
12:00pm
Viatris to Participate in the UBS Global Healthcare Conference and Jefferies London Healthcare Conference
PRNewswire
•
9:00am
Oct 16, 2024
Viatris Announces Exclusive Licensing Agreement with Lexicon Pharmaceuticals for Sotagliflozin in all Markets Outside of the U.S. and Europe
PRNewswire
•
4:00pm
Oct 15, 2024
Viatris Settles Lawsuit, Avoids Antitrust Charges, and Advances Effexor Study
Shanti Putri
•
4:14pm
Viatris Inc (VTRS) Shares Up 4.08% on Oct 15
GuruFocus News
•
11:06am
Viatris 2023 Sustainability Report: Addressing Critical Health and Social Needs in India
ACCESSWIRE
•
11:00am
Oct 10, 2024
Viatris 2023 Sustainability Report: Reducing Packaging Material
ACCESSWIRE
•
11:00am
Oct 09, 2024
Viatris Inc (VTRS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations
GuruFocus News
•
3:38pm
Q2 2024 Viatris Inc Earnings Call Transcript
GuruFocus News
•
1:39pm
Viatris Announces Positive Top-line Results from Phase 3 Study of EFFEXOR® in Japanese Adults with Generalized Anxiety Disorder (GAD)
PRNewswire
•
6:00am
Oct 08, 2024
Viatris Named to Forbes' Annual List of the World's Best Employers for the Fourth Year in a Row
ACCESSWIRE
•
3:00pm
Viatris Named to Forbes' Annual List of the World's Best Employers for the Fourth Year in a Row
PRNewswire
•
11:00am
Viatris 2023 Sustainability Report: Expanding Contractor Training
ACCESSWIRE
•
7:00pm
Sep 20, 2024
Viatris Inc (VTRS) Shares Down 5.34% on Sep 20
GuruFocus Research
•
10:03am
Sep 19, 2024
In Europe, Packaging Site Takes Flight as a Bird-Friendly Workplace
ACCESSWIRE
•
3:00pm
Viatris 2023 Sustainability Report: Health and Safety in the Workplace
ACCESSWIRE
•
11:00am
Sep 18, 2024
Viatris Announces the Pricing Terms of Maximum Tender Offer
PRNewswire
•
11:00am
Viatris Announces Early Tender Results and Increase of Pending Maximum Tender Offer
PRNewswire
•
8:00pm
Sep 16, 2024
Viatris to Report Third Quarter 2024 Financial Results on November 7, 2024
PRNewswire
•
4:00pm
From Opposite Ends of the Earth, the Same Story: Women Push for Positive Change
ACCESSWIRE
•
11:00am
Sep 12, 2024
Viatris Inc (VTRS) Shares Up 3.35% on Sep 12
GuruFocus Research
•
11:03am
Viatris 2023 Sustainability Report: Advocating for Patients
ACCESSWIRE
•
11:00am
Sep 11, 2024
Viatris Announces Expiration and Results of Any and All Cash Tender Offers
PRNewswire
•
7:00pm
Sep 10, 2024
Viatris Announces the Pricing Terms of Pending Any and All Cash Tender Offers
PRNewswire
•
11:00am
Sep 09, 2024
Viatris 2023 Sustainability Report: Breaking Down Systemic Barriers To Access Through Policy Engagement
ACCESSWIRE
•
11:00am
Sep 04, 2024
Viatris 2023 Sustainability Report: Continued Innovation for Infectious Disease
ACCESSWIRE
•
11:00am
Viatris Announces Cash Tender Offers for Certain Outstanding Notes
PRNewswire
•
3:00am
Total 37
1
Show
20
40
60
80
100
No data
Entries
Headlines
Total 0
1
No recent news